[go: up one dir, main page]

DK2909314T3 - Behandling af smerte med amnion afledte vedhæftende celler - Google Patents

Behandling af smerte med amnion afledte vedhæftende celler Download PDF

Info

Publication number
DK2909314T3
DK2909314T3 DK13846458.1T DK13846458T DK2909314T3 DK 2909314 T3 DK2909314 T3 DK 2909314T3 DK 13846458 T DK13846458 T DK 13846458T DK 2909314 T3 DK2909314 T3 DK 2909314T3
Authority
DK
Denmark
Prior art keywords
pain
treatment
adherent cells
derived adherent
amnion derived
Prior art date
Application number
DK13846458.1T
Other languages
English (en)
Inventor
Uri Herzberg
Robert J Hariri
Jodi P Gurney
Original Assignee
Celularity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celularity Inc filed Critical Celularity Inc
Application granted granted Critical
Publication of DK2909314T3 publication Critical patent/DK2909314T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK13846458.1T 2012-10-19 2013-10-18 Behandling af smerte med amnion afledte vedhæftende celler DK2909314T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261716091P 2012-10-19 2012-10-19
US201361783752P 2013-03-14 2013-03-14
PCT/US2013/065653 WO2014063035A2 (en) 2012-10-19 2013-10-18 Treatment of pain using amnion derived adherent cells

Publications (1)

Publication Number Publication Date
DK2909314T3 true DK2909314T3 (da) 2021-03-08

Family

ID=50488901

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13846458.1T DK2909314T3 (da) 2012-10-19 2013-10-18 Behandling af smerte med amnion afledte vedhæftende celler

Country Status (7)

Country Link
US (1) US20160166618A1 (da)
EP (1) EP2909314B1 (da)
JP (4) JP2015536326A (da)
CA (1) CA2888772A1 (da)
DK (1) DK2909314T3 (da)
HK (1) HK1214299A1 (da)
WO (1) WO2014063035A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3068432A4 (en) 2013-11-15 2017-04-19 Anthrogenesis Corporation Compositions comprising human placental perfusate cells, subpopulations thereof, and their uses
CN113679741B (zh) * 2021-09-13 2023-09-19 北京大学第一医院 人羊膜上皮干细胞在制备治疗顺铂诱导的急性肾损伤的药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100696407B1 (ko) 1999-04-16 2007-03-19 더블유엠. 마쉬 라이스 유니버시티 폴리(프로필렌 푸마레이트)-디아크릴레이트 마크로머와가교결합된 생분해성 폴리(프로필렌 푸마레이트) 네트워크
US6355699B1 (en) 1999-06-30 2002-03-12 Ethicon, Inc. Process for manufacturing biomedical foams
EP1334104A2 (en) * 2000-07-07 2003-08-13 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions
CA3046566A1 (en) 2001-02-14 2002-08-22 Anthrogenesis Corporation Post-partum mammalian placental stem cells for use in the treatment of neurological or renal diseases and disorders
PT2471906T (pt) 2005-12-29 2019-02-06 Celularity Inc Populações de células estaminais da placenta
US20090214484A1 (en) * 2008-02-22 2009-08-27 Nikolay Mironov Stem cell therapy for the treatment of central nervous system disorders
RU2562154C2 (ru) * 2008-11-19 2015-09-10 Антродженезис Корпорейшн Амниотические адгезивные клетки
MX2012006246A (es) * 2009-11-30 2012-06-19 Pluristem Ltd Celulas adherentes de placenta y su uso en el tratamiento de enfermedades.
NZ609921A (en) * 2010-11-16 2014-11-28 Giuseppe Marineo Apparatus and method for rapid suppression of neuropathic, oncological, and paediatric pain, resistant to opiates and to conventional electro-analgesia
KR20180100250A (ko) * 2010-12-17 2018-09-07 안트로제네시스 코포레이션 양막 유래 부착성 세포를 사용한, 면역-관련 질환 및 장애의 치료
AR084753A1 (es) * 2010-12-30 2013-06-05 Anthrogenesis Corp Composiciones que comprenden celulas adherentes derivadas del saco amniotico (amdac) y plasma rico en plaquetas (prp)

Also Published As

Publication number Publication date
JP7315755B2 (ja) 2023-07-26
HK1214299A1 (zh) 2016-07-22
US20160166618A1 (en) 2016-06-16
JP2018188456A (ja) 2018-11-29
CA2888772A1 (en) 2015-04-24
JP2022130406A (ja) 2022-09-06
EP2909314B1 (en) 2020-12-02
WO2014063035A3 (en) 2014-06-19
JP2020180128A (ja) 2020-11-05
EP2909314A4 (en) 2016-10-12
WO2014063035A2 (en) 2014-04-24
EP2909314A2 (en) 2015-08-26
JP2015536326A (ja) 2015-12-21

Similar Documents

Publication Publication Date Title
DK2931752T3 (da) Behandling af cd47+ sygdomsceller med sirp-alpha-fc-fusioner
DK2890836T3 (da) Fremgangsmåder i forbindelse med modulatorer af eukaryotiske celler
DK3501549T3 (da) Behandling af amd med aav sflt-1
FR2995619B3 (fr) Structure de fixation de robinet
IL228701A0 (en) Bcma-based stratification and therapy for multiple myeloma patients
BR112013022813A2 (pt) diaminocarbonitrila pirimidinas e diaminocarboxamida substituída, composições das mesmas e métodos de tratamento com as mesmas
LT2885010T (lt) Tautopatijos gydymo būdai
DK3281607T3 (da) Implanterbar protese med acellulære vævsvedhæftninger.
DK2818241T3 (da) Fremgangsmåde til fremstilling af behandlingsapparat udstyret med katalysatorbærende honeycombstruktur
EP2731440A4 (en) RADIATION LESSON TREATMENT USING ADHESENT CELLS DERIVED FROM AMNIOS
DK2925889T3 (da) Diagnostiske markører til behandling af celleproliferationsforstyrrelser med telomeraseinhibitorer
DK2903432T3 (da) Fremgangsmåde til behandling af sædceller til kønsortering
EP2696949A4 (en) BINDING
EP2780012A4 (en) Methods of treatment with deferiprone
DK3446565T3 (da) Fremgangsmåder til behandling af antipsykotika-induceret vægtøgning
EP2543396A4 (en) ARTIFICIAL SKIN
DK2830645T3 (da) Neuregulin til anvendelse i behandling af perifær nervelæsion
EP2810665A4 (en) bio-implant
HK1223967A1 (zh) 人誘導多能幹細胞衍生的心肌細胞的內向整流的電子表達
DK3132684T3 (da) Behandling af fiskepopulationer med lufenuron
FR2987600B1 (fr) Nacelle aplatie de turboreacteur
DK2820042T3 (da) Igg-stimuleret remyelinisering af perifere nerver
DK2916922T3 (da) Behandling af alkalisk bauxitrest
DK2825636T3 (da) Behandling af sædceller
FI9862U1 (fi) Suuntaajan kytkentähaara ja kolmitasoinen suuntaaja